Feed AARTIDRUGS.NS
AA

Aarti Drugs Limited

AARTIDRUGS.NS · NSE

₹428.00 +3.13% (+₹13.00)
1M -1.89%
Market Cap ₹37.8B
P/E Ratio 19.79x
Div. Yield -
ROE 13.06%

Bulios Fair Price

₹249.28

41.8% downside

Current Price

₹428

Undervalued Fair Value Overvalued

According to Bulios Fair Price, AARTIDRUGS.NS is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
4/9
Valuation
47 /100
Fair
P/E 19.79x
EV/EBITDA 13.02x
P/S 1.41x
Growth
18 /100
Declining
EPS growth 6.07%
Rev. growth 1.38%
Book val. growth 9.72%
Profitability
40 /100
Moderate
Gross margin 31.68%
Net margin 7.14%
Op. margin 9.81%
Quality
62 /100
Average
ROIC 9.90%
ROE 13.06%
ROA 6.79%
Debt
79 /100
Low
Debt/Equity 0.37x
Current ratio 1.59x
Int. coverage 7.66x
Stability
99 /100
Stable
Beta 0.88x
Rev. volatility 8.91%
EPS volatility 11.86%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about AARTIDRUGS.NS
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Prakash Moreshwar Patil

Employees

1,064

Headquarters

Mumbai

Upcoming events

22 OCT

Earnings

Upcoming earnings report

16d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.